Compositions and methods for imparting a sunless tan with a vicinal diamine

Information

  • Patent Grant
  • 8821839
  • Patent Number
    8,821,839
  • Date Filed
    Friday, October 22, 2010
    13 years ago
  • Date Issued
    Tuesday, September 2, 2014
    9 years ago
Abstract
A composition and method for imparting a sunless tan to skin is described. The composition and method makes use of a sunless tanning agent like dihydroxyacetone in combination with an adjuvant which is a vicinal diamine.
Description
FIELD OF THE INVENTION

The present invention is directed to a composition and method for imparting a sunless tan to skin. More particularly, the invention is directed to a composition and method that employ a sunless tanning agent as well as an adjuvant for the sunless tanning agent. The composition, when applied, unexpectedly results in the consumer having skin with a brownish/tan coloration (i.e., a sunless tan) within a consumer acceptable time and in the absence of undesirable orange coloration.


BACKGROUND OF THE INVENTION

Sunless tanning agents are formulated into two types of cosmetic products. Of these, the most traditional is the self-tanning lotion. The imparted benefit is to achieve a skin coloration equivalent to that from basking in the sun. More recently, a second product category has arrived. Therein a sunless tanning agent in small amounts is added to a typical moisturizing lotion. A “glow or shine” is thereby imparted. Glow or shine is a major factor in the appearance of healthy looking skin.


Most prominent among the sunless tanning agents is dihydroxyacetone (“DHA” which is also chemically known as 1,3-dihydroxy-2-propanone). DHA, after application, is believed to exert its effect through interactions between, for example, its keto group and the amino groups of amino acids and peptides naturally occurring in the stratum corneum of the skin. These so-called Maillard reactions are believed (see, e.g., Bobin et al., J. Soc. Cosmet. Chem. 35: 255 (1984)) to lead to formation of brown pigments in the skin, thereby giving it an appearance similar to that of a naturally obtained tan.


Unfortunately, many sunless tanning products available on the market are not stable in that they turn a yellow and/or orange color after application, especially when exposed to UV light. Other sunless tanning products perform poorly and do not quickly impart a noticeable brown color after application. These poorly performing products do not discourage “tan-happy” consumers from basking in the sun. Such behavior then leads to consumers with skin over exposed to the sun's harmful ultraviolet rays.


There is increasing interest to develop compositions and methods for imparting a sunless tan. This invention, therefore, is directed to a composition and method that employ a sunless tanning agent as well as an adjuvant for the sunless tanning agent. The composition, when applied, unexpectedly results in the consumer having skin with a natural brownish/tan coloration within a consumer acceptable time and, surprisingly, does not turn orange and/or yellow after application.


Additional Information


Efforts have been disclosed for making self-tanning cosmetic compositions. In U.S. Pat. Nos. 5,232,688 and 5,612,044, self-tanner compositions with DHA are described.


Other efforts have been disclosed for making self-tanning compositions. In U.S. Pat. No. 5,750,092, compositions with DHA and secondary amines are described.


Still other efforts have been disclosed for making self-tanning compositions. In U.S. Pat. No. 6,231,837, self tanning formulations comprising DHA, polyethoxyglycol and a polyol are described.


Even other efforts have been disclosed for creating sunless tans. In U.S. Pat. Nos. 5,645,822 and 5,756,075, and Published Patent Application No. 2005/0089486, sunless tanning concepts are described.


None of the additional information describes a method and/or composition that yield excellent sunless tanning results whereby the composition and method employ a sunless tanning agent and a vicinal diamine as claimed herein.


SUMMARY OF THE INVENTION

In a first aspect, the present invention is directed to a composition comprising:

    • a) a sunless tanning agent; and
    • b) an adjuvant for the sunless tanning agent, the adjuvant comprising a vicinal diamine


wherein at least about 50% by weight of the vicinal diamine is not loaded onto a microparticle delivery system.


In a second aspect, the present invention is directed to a method for generating a sunless tan comprising the step of applying to the skin the composition of the first aspect of this invention.


All other aspects of the present invention will more readily become apparent upon considering the detailed description and examples which follow.


Sunless tanning, as used herein, means obtaining the suntan look by applying a topical composition. The same can be interchanged with self-tanning. Composition, as used herein, is meant to include a substance applied to a human body for imparting a sunless tan where the composition is for example, a leave-on skin lotion, cream or mousse, shampoo, hair conditioner, shower gel, toilet bar, body wash, shaving cream, body wax, depilatory, mascara, sunscreen product or the like. Such a composition may also be put on body towelettes for application to the body. In a preferred embodiment, the composition of this invention is a lotion or cream. Consumer acceptable time means within about 3 to about 6 hours from application, and preferably, from about 1 to about 2 hours, and most preferably, from about 15 to about 30 minutes subsequent to application. Microparticle delivery system, as used herein, is meant to mean a delivery system using adsorbent microparticle polymers like, for example, those sold under the name Poly-Pore® E200 and PolyTrap®, both of which are made commercially available from suppliers like AMCOL International Corp.


Comprising, as used herein, is meant to include consisting essentially of and consisting of. Therefore, for example, the adjuvant used in the present invention may consist essentially of or consist of vicinal diamine. All ranges identified herein are meant to include all ranges subsumed therein if, for example, reference to the same is not explicitly made.







DETAILED DESCRIPTION OF THE INVENTION

The sunless tanning agent suitable for use in this invention is only limited to the extent that the same may be applied topically by humans to form pigmented components. Such materials may be alpha-hydroxyaldelydes and ketones, glyceraldehyde, troxerutin and related alcohol aldehydes, various indoles, imidazoles as well as mixtures and derivatives thereof.


Illustrative yet non-limiting examples of the sunless tanning agents that may be used in this invention include DHA, melanin, mahakanni (eclipta alba), methyl glyoxal, erythrulose, alloxan, 2,3-dihydroxysuccindialdehyde, mixtures thereof, or the like. In a preferred embodiment, the sunless tanning agent used is dihydroxyacetone, erythrulose or a mixture thereof. In a most preferred embodiment, the sunless tanning agent is DHA.


Typically, suitable sunless tanning agent makes up from about 0.025 to about 35%, and preferably, from about 0.05 to about 15%, and most preferably, from about 0.5 to about 10% by weight of the composition (i.e., the composition suitable for topical application by a consumer), based on total weight of the composition and including all ranges subsumed therein.


The adjuvant (i.e., vicinal, primary diamine) that may be used in this invention is limited only to the extent that the same may be used in a composition suitable for topical application to humans.


Typically, suitable vicinal diamine is represented by the formula:




embedded image



wherein

  • a and b are each independently zero or 1;
  • R is H, or C1-4 alkyl when a is zero and CH—X when a is 1;
  • R1 is H or C1-4 alkyl when b is zero and CH—X when b is 1;
  • when a is 1, R2 is H, C1-4 alkyl or a C1-3 alkoxy when b is zero, and CH—X or Y
  • when b is 1;
  • when b is 1, R3 is H, C1-4 alkyl or a C1-3 alkoxy when a is zero, and CH—X or Y
  • when a is 1;
  • each X is independently H, OH, C1-3 alkyl or —CH2(CH2)nOH where n is an integer from zero to 2;
  • Y is oxygen or NR4; and
  • each R4 is independently H, C1-6 alkyl, aryl or —CH2—(CH2)m—OH where m is an integer from about 0 to about 4.


Included within the scope of this invention are the geometric isomers of the above-identified vicinal diamines.


In an often preferred embodiment, at least about 50%, and preferably, at least about 65%, and most preferably, from 75 to 100% by weight vicinal diamine is not loaded onto a microparticle delivery system. Most preferably, the adjuvant of this invention is added to the composition as an ingredient or additive free of any delivery or additive system.


If optionally used, microparticle delivery system may extend the life of sunless tanning agent and/or assist in suspending non-soluble ingredients within the composition. Such particles may be made by combining from about 1 to about 3 parts by weight adjuvant to about 3 to 1 parts by weight microparticle polymer. Preferred microparticle polymers include PolyPore® E200, Poly-Pore L200 and PolyTrap®, all of which are made commercially from AMCOL International Corporation. A more detailed description of such a microparticle delivery system is described in U.S. patent Application No. 2005/0089486, the disclosure of which is incorporated herein by reference.


In a preferred embodiment, the adjuvant employed in this invention and represented by the formula is ethylene diamine, 1,2-diamino propane, 1,2-diamino cyclohexane, 3,4-diamino-6-hydroxymethyl-tetrahydro-pyran-2,5-diol, a mixture thereof or the like. In a more preferred embodiment, the adjuvant used is the 1,2-diamino propane, 1,2-diamino cyclohexane or a mixture thereof.


In a most preferred embodiment, the pH of the composition of this invention is from about 2.6 to less than 3.8, and preferably, from about 2.7 to about 3.7, and most preferably, from about 3.0 to about 3.5, including all ranges subsumed therein. In an especially preferred embodiment, the pH of the composition is from about 3.0 to about 3.5 when at least about 50% by weight of total adjuvant and especially all adjuvant used is ethylene diamine.


Typically, adjuvant makes up from about 0.025 to about 35%, and preferably, from about 0.05 to about 15%, and most preferably, from about 0.5% to about 8% by weight of the composition, including all ranges subsumed therein.


Compositions of the present invention will typically include a cosmetically acceptable carrier. Water is the most preferred carrier. Amounts of water may range from about 1 to about 99%, and preferably, from about 5 to about 90%, and most preferably, from about 35 to about 80% and optimally from about 40 to about 75% by weight, based on total weight of the composition and including all ranges subsumed therein. Ordinarily the compositions will be water and oil emulsions, most preferably, of the oil-in-water variety. Water-in-oil emulsions, and especially, those generally classified as water-in-oil and high internal phase emulsions are, however, an option. Illustrative examples of the high internal phase emulsions suitable to carry the actives and adjuvants of this invention described in commonly owned U.S. Patent Application Publication Nos. 2008/0311058 and 2009/0247445, the disclosures of which are incorporated herein by reference.


Other cosmetically acceptable carriers may include mineral oils, silicone oils, synthetic or natural esters, fatty acids and alcohols. Amounts of these materials may range from about 0.1 to about 50%, and preferably, from about 0.1 to about 30%, and most preferably, from about 1 to about 20% by weight of the composition, including all ranges subsumed therein.


Silicone oils may be divided into the volatile and non-volatile variety. The term “volatile” as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from about 3 to about 9, and preferably, from about 4 to about 5 silicon atoms.


Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25° C. while cyclic materials typically have viscosities of less than about 10 centistokes.


Nonvolatile silicone oils useful as carrier material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethylsiloxanes (like dimethicone) with viscosities of from about 5 to about 100,000 centistokes at 25° C.


An often preferred silicone source is a cyclopentasiloxane and dimethiconol solution.


Among suitable esters are:

    • (1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms like isopropyl palmitate, isopropyl isostearate, isononyl isononanoate, oleyl myristate, oleyl stearate, and oleyl oleate;
    • (2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols;
    • (3) Polyhydric alcohol esters such as ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxy-ethylene sorbitan fatty acid esters;
    • (4) Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate; and
    • (5) Sterol esters, of which soya sterol and cholesterol fatty acid esters are examples thereof.


Fatty acids having from 10 to 30 carbon atoms may be included in the compositions of this invention. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids.


Emulsifiers may be present in the compositions of the present invention. Total concentration of the emulsifier may range from about 0.1 to about 40%, and preferably, from about 1 to about 20%, and most preferably, from about 1 to about 5% by weight of the composition, including all ranges subsumed therein. The emulsifier may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic actives are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from about 2 to about 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di-C8-C20 fatty acids; and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic emulsifiers.


Preferred anionic emulsifiers include soap, alkyl ether sulfate and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isethionates, C8-C20 alkyl ether phosphates, alkylethercarboxylates and combinations thereof.


Cationic emulsifiers that may be used include, for example, palmitamidopropyltrimonium chloride, distearyldimonium chloride and mixtures thereof. Useful amphoteric emulsifiers include cocoamidopropyl betaine, C12-C20 trialkyl betaines, sodium lauroamphoacetate, and sodium laurodiamphoacetate or a mixture thereof.


Other generally preferred emulsifiers include glyceryl stearate, glycol stearate, stearamide AMP, PEG-100 stearate, cetyl alcohol as well as emulsifying/thickening additives like hydroxyethylacrylate/sodium acryloyldimethyl taurates copolymer/squalane and mixtures thereof.


Preservatives can desirably be incorporated into the compositions comprising the sunless tanning agent and adjuvant of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are iodopropynyl butyl carbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from about 0.01% to about 2% by weight of the composition, including all ranges subsumed therein.


Thickening agents may be included in compositions of the present invention. Particularly useful are the polysaccharides. Examples include starches, natural/synthetic gums and cellulosics. Representative of the starches are chemically modified starches such as sodium hydroxypropyl starch phosphate. Tapioca starch is an often desired option. Suitable gums include xanthan, sclerotium, pectin, karaya, arabic, agar, guar, carrageenan, alginate and combinations thereof. Suitable cellulosics include hydroxypropyl cellulose, hydroxypropyl methylcellulose, and ethylcellulose.


Amounts of the thickener may range from about 0.001 to about 5%, and preferably, from about 0.1 to about 2%, and most preferably, from about 0.2 to about 0.5% by weight of the composition including all ranges subsumed therein.


Fragrances, fixatives and abrasives may optionally be included in compositions of the present invention. Each of these substances may range from about 0.05 to about 5%, preferably between 0.1 and 3% by weight.


To enhance skin moisturization, cationic ammonium compounds may optionally be used in the compositions of this invention. Such compounds include salts of hydroxypropyltri (C1-C3 alkyl) ammonium mono-substituted-saccharide, salts of hydroxypropyltri (C1-C3 alkyl) ammonium mono-substituted polyols, dihydroxypropyltri (C1-C3 alkyl) ammonium salts, dihydroxypropyldi (C1-C3 alkyl) mono(hydroxyethyl) ammonium salts, guar hydroxypropyl trimonium salts, 2,3-dihydroxypropyl tri(C1-C3 alkyl or hydroxalkyl) ammonium salts or mixtures thereof. In a most preferred embodiment and when desired, the cationic ammonium compound employed in this invention is the quaternary ammonium compound 1,2-dihydroxypropyltrimonium chloride. If used, such compounds typically make up from about 0.01 to about 30%, and preferably, from about 0.1 to about 15% by weight of the composition.


When cationic ammonium compounds are used, optional additives for use with the same are moisturizing agents such as substituted ureas like hydroxymethyl urea, hydroxyethyl urea, hydroxypropyl urea; bis(hydroxymethyl)urea; bis(hydroxyethyl)urea; bis(hydroxypropyl)urea; N,N′-dihydroxymethyl urea; N,N′-di-hydroxyethyl urea; N,N′-di-hydroxypropyl urea; N,N,N′-tri-hydroxyethyl urea; tetra(hydroxymethyl)urea; tetra(hydroxyethyl)urea;


tetra(hydroxypropyl)urea; N-methyl-N′-hydroxyethyl urea; N-ethyl-N′-hydroxyethyl urea; N-hydroxypropyl-N′-hydroxyethyl urea and N,N′dimethyl-N-hydroxyethyl urea or mixtures thereof. Where the term hydroxypropyl appears, the meaning is generic for either 3-hydroxy-n-propyl, 2-hydroxy-n-propyl, 3-hydroxy-i-propyl or 2-hydroxy-i-propyl radicals. Most preferred is hydroxyethyl urea. The latter is available as a 50% aqueous liquid from the National Starch & Chemical Division of ICI under the trademark Hydrovance. Such substituted ureas, while desirable in moisturizing formulations, are only selected for use when compatible with the desired sunless tanning agent or agents used in the compositions of this invention.


Amounts of substituted urea, when used, in the composition of this invention range from about 0.01 to about 20%, and preferably, from about 0.5 to about 15%, and most preferably, from about 2 to about 10% based on total weight of the composition and including all ranges subsumed therein.


When cationic ammonium compound and substituted urea are used, in a most especially preferred embodiment at least from about 0.01 to about 25%, and preferably, from about 0.2 to about 20%, and most preferably, from about 1 to about 15% humectant, like glycerine, is used, based on total weight of the composition and including all ranges subsumed therein.


In the absence of cationic ammonium compound and substituted urea, conventional humectants may, nevertheless, be employed in the present invention. These are generally polyhydric alcohol-type materials. Typical polyhydric alcohols include glycerol (i.e., glycerine or glycerin), propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. Most preferred is glycerin, propylene glycol or a mixture thereof. The amount of humectant employed in the absence of cationic ammonium compound and substituted urea may range anywhere from 0.5 to 30%, preferably between 1 and 15% by weight of the composition.


Compositions of the present invention may include vitamins. Illustrative vitamins are Vitamin A (retinol), Vitamin B2, Vitamin B3 (niacinamide), Vitamin B6, Vitamin C, Vitamin E, Folic Acid and Biotin. Derivatives of the vitamins may also be employed. For instance, Vitamin C derivatives include ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate and ascorbyl glycoside. Derivatives of Vitamin E include tocopheryl acetate, tocopheryl palmitate and tocopheryl linoleate. DL-panthenol and derivatives may also be employed. Total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the end use composition.


A variety of herbal extracts may optionally be included in compositions of this invention. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents. Illustrative extracts include those from green tea, yarrow, chamomile, licorice, aloe vera, grape seed, citrus unshui, willow bark, sage, thyme and rosemary.


Also optionally suitable for use include materials like lipoic acid, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B and Ceramide 6) as well as pseudoceramides may also be useful. Amounts of these materials may range from about 0.000001 to about 10%, preferably from about 0.0001 to about 1% by weight of the composition.


Conventional buffers/pH modifiers may be used. These include commonly employed additives like sodium hydroxide, hydrochloric acid, citric acid and citrate/citric acid buffers.


Colorants, opacifiers, chelators (like tetrasodium EDTA) and abrasives may also be included in the compositions of the present invention. Each of these substances may range from about 0.05 to about 5%, preferably between 0.1 and 3% by weight of the composition.


In an especially preferred embodiment, the composition of the present invention comprises less than about 5%, and preferably, from 0.01 to 4% glycine, and most preferably, no glycine.


A wide variety of packaging can be employed to store and deliver the compositions. Packaging is often dependent upon the type of personal care end-use. For instance, leave-on skin lotions and creams, shampoos, conditioners and shower gels generally employ plastic containers with an opening at a dispensing end covered by a closure. Typical closures are screw-caps, non-aerosol pumps and flip-top hinged lids. Packaging for antiperspirants, deodorants and depilatories may involve a container with a roll-on ball on a dispensing end. Alternatively these types of personal care products may be delivered in a stick composition formulation in a container with propel-repel mechanism where the stick moves on a platform towards a dispensing orifice. Metallic cans pressurized by a propellant and having a spray nozzle serve as packaging for antiperspirants, shave creams and other personal care products. Toilette bars may have packaging constituted by a cellulosic or plastic wrapper or within a cardboard box or even encompassed by a shrink wrap plastic film.


Preferably, the composition of this invention may be divided so that a first portion carries sunless tanning agent and a second portion may carry adjuvant. When dividing the composition, each portion should be packaged separately from each other and not come into contact with each other until application to the body. The packaging for dual compositions is known and commercially available. Upon application, the make up of the composition (i.e., the combined portions) is as described herein.


When making the composition of the present invention, ingredients may be combined in no particular order. Typically the ingredients are combined and mixed under conditions of moderate shear and at ambient temperature with pressure being atmospheric conditions. In a most preferred embodiment, DHA and adjuvant are not added at a time when mixing and heating are desired and at a point where their concentrations would be high with respect to each other. When applied by the consumer, typically from about 1 to 5 mg, and preferably, from about 1 to 4 mg, and preferably, from about 1.5 to 2.5 mg per square centimeter of composition is applied to body surface (like skin) and including all ranges subsumed therein.


The following examples are provided to facilitate an understanding of the present invention. The examples are not intended to limit the scope of the claims.


Example 1

The utility of the inventive adjuvants in sunless-tanning compositions is illustrated in the following samples shown in Table I, all of which were made by mixing ingredients with moderate shear under atmospheric conditions and ambient temperature.











TABLE I









Sample (% by weight)












Ingredient
E1
E2
E3
















Sodium hydroxypropyl starch
0.10
0.10
0.10



phosphate



Chelator
0.11
0.11
0.11



Preservative
0.3
0.3
0.3



Glycerin
12.0
12.0
12.0



Citric acid*
0.1-0.2
0.1-0.2
0.1-0.2



Colorant
0.19
0.19
0.19



Stearic acid
1.97
1.97
1.97



Emulsifier
4.2
4.2
4.2



Cetyl alcohol
0.31
0.31
0.31



Isopropyl palmitate
2.25
2.25
2.25



Silicone oil
1.5
1.5
1.5



Phenoxyethanol
0.4
0.4
0.4



Fragrance
0.35
0.35
0.35



Dihydroxyacetone
2.5
0.0
0.0



Alloxan
0.0
2.5
0.0



Erythrulose
0.0
0.0
2.5



1,2-Diamino cyclohexane
1.0
1.0
1.0



Deionized water
balance
balance
balance







*to pH of about 3.3






Samples E1 to E3 were assessed for efficacy and all gave coloration to synthetic skin (made available under the Vitro-Skin® name). The synthetic skin was pre-hydrated at 95% RH for 24 hours and then treated with portions of the samples at a dosage of 5 μL/cm2. The treated synthetic skin was then stored at 35° C. and 40% RH for periods up to 24 hours. Color development was monitored after about three (3) hours of treatment using a HunterLab Labscan XE colorimeter. The overall color of the treated skin was noted in terms of the Individual Typologic Angle ITA°=180 (Arc Tangent ((L*−50/b*))/π, as defined by A. Chardon et al. in the International Journal of Cosmetic Science, Volume 13, pages 191-208 (1991). When comparing skin treated with compositions having no adjuvant, samples (E1-E3) made according to this invention resulted in skin showing a large difference in ITA° (i.e., ΔITA° of about 40) indicating a darker tan/color. The results demonstrated that the inventive adjuvants of this invention work well across a broad range of sunless tanning actives and in compositions ready for use by consumers.


Example 2

The utility of the inventive ingredients in sunless-tanning compositions was also illustrated in the following samples shown in Table II, all of which were prepared as described above.











TABLE II









Sample (% by weight)












Ingredients
E4
E5
E6
















Thickening agent
0.25
0.25
0.25



Tapioca starch
0.5
0.5
0.5



Chelator
0.05
0.05
0.05



Preservative
0.3
0.3
0.3



Glycerin
12.0
12.0
12.0



Citric acid*
0.02
0.02
0.02



Colorant
0.19
0.19
0.19



Glyceryl stearate
2.4
2.4
2.4



PEG 100 stearate
1.2
1.2
1.2



Cetyl alcohol
2.4
2.4
2.4



Isopropyl palmitate
2.0
2.0
2.0



Wax
1.0
1.0
1.0



Dimethicone 50 cst
3.0
3.0
3.0



Phenoxyethanol
0.4
0.4
0.4



Fragrance
0.35
0.35
0.35



Dihydroxyacetone
2.5
0.0
0.0



Alloxan
0.0
2.5
0.0



Erythrulose
0.0
0.0
2.5



Ethylene diamine
1.0
1.0
1.0



Deionized water
to 100
to 100
to 100







*to pH of about 3.3






To assess the effect of the adjuvants of this invention on coloration, a change in the Individual Typological Angle, with and without adjuvant, was determined as a function of time using synthetic skin and in a manner similar to the one described in Example 1. The large values of ΔITA° signify darker tanning or coloring.


The change in the Individual Typologic Angle)(ITA° for synthetic skin 3 hours after treatment with a variety of sunless tanning agents and adjuvant consistent with this invention is shown in Table III.












TABLE III








Δ ITA ° for




ethylene diamine



Sample
vs. no adjuvant









E4
42



E5
37



E6
38










The results in Table III indicate that adjuvant consistent with this invention unexpectedly enhances coloration within a ready to use composition.


Example 3

Formulations in Table IV containing 2.5% DHA and the molar equivalent of 1% glycine as adjuvant in a citric acid/citrate buffer solution were prepared. The formulations were adjusted to a pH of about 5.5 to mimic the formulation pH after application to human skin.













TABLE IV








ΔITA ° after
ΔITA ° after



Adjuvant
2 hours
4 hours









None
0.5 ± 0.5
 0.5 ± 0.5



Glycine
2 ± 1
 7 ± 2



1,2-diamino cyclohexane
20 ± 3 
35 ± 3



Ethylene diamine
16 ± 2 
32 ± 3



1,2-diamino propane
17 ± 2 
32 ± 3



3,4-diamino-6-hydroxymethyl-
15 ± 3 
23 ± 2



tetrahydro-pyrane 2,5-diol



1,3-diamino propane
6 ± 3
16 ± 4



1,4-diamino butane
4 ± 2
12 ± 4



N,N-dimethyl ethylene diamine
4 ± 2
 8 ± 2










Individual Typologic Angle results were obtained in a manner similar to the one described in Example 1. The results unexpectedly demonstrate that adjuvants of this invention and having adjacent (vicinal) amines resulted in greater skin darkening when compared to non-vicinal diamines such as 1,3-diamino propane, 1,4-diamino propane and non-primary diamines like N,N-dimethyl ethylene diamine.

Claims
  • 1. A composition comprising: a) a sunless tanning agent; andb) an adjuvant for the sunless tanning agent, the adjuvant comprising a vicinal primary diamine having the formula
  • 2. The composition according to claim 1 wherein the sunless tanning agent is dihydroxyacetone, melanin, mehakanni, methyl glyoxal, erythrulose, alloxan, 2,3-dihydroxysuccindialdehyde or a mixture thereof.
  • 3. The composition according to claim 1 wherein the sunless tanning agent is dihydroxyacetone.
  • 4. The composition according to claim 1 wherein from about 75 to 100 percent by weight adjuvant is not loaded onto a microparticle delivery system.
  • 5. The composition according to claim 1 wherein the vicinal primary diamine is 1,2-diamino cyclohexane.
  • 6. The composition according to claim 1 wherein the vicinal primary amine further comprises ethylene diamine, 1,2-diamino propane, 3,4-diamino-6-hydroxymethyl-tetrahydro-pyran-2,5-diol or a mixture thereof.
  • 7. The composition according to claim 1 wherein the adjuvant further comprises ethylene diamine.
  • 8. The composition according to claim 1 wherein the adjuvant makes up from about 0.025 to about 35% by weight of the composition.
  • 9. The composition according to claim 1 wherein the composition has a pH from about 2.6 to less than 3.8.
  • 10. The composition according to claim 7 wherein the composition has a pH from about 3 to about 3.5.
  • 11. The composition according to claim 1 wherein the sunless tanning agent makes up from about 0.025 to about 35% by weight of the composition.
  • 12. A method for imparting a sunless tan to skin comprising the step of applying to the skin the composition of claim 1.
US Referenced Citations (135)
Number Name Date Kind
3892881 Lissant Jul 1975 A
4104403 Barker Aug 1978 A
4246285 Van Duzee Jan 1981 A
4385049 Cuca May 1983 A
4405616 Rajadhyaksha Sep 1983 A
4446051 Berthod et al. May 1984 A
4606913 Aronson Aug 1986 A
4808610 Munayyer et al. Feb 1989 A
4886783 Minaskanian et al. Dec 1989 A
4981845 Pereira Jan 1991 A
5118845 Peck et al. Jun 1992 A
5131911 Lang et al. Jul 1992 A
5232688 Ziegler et al. Aug 1993 A
5387417 Rentsch Feb 1995 A
5412004 Tachibana et al. May 1995 A
5489429 Griat et al. Feb 1996 A
5523075 Fuerst et al. Jun 1996 A
5612044 Suares et al. Mar 1997 A
5645822 Meyer et al. Jul 1997 A
5700452 Deckner et al. Dec 1997 A
5705145 Miklean et al. Jan 1998 A
5720948 Brucks et al. Feb 1998 A
5750092 Meyer et al. May 1998 A
5756075 Meyer May 1998 A
5814659 Elden Sep 1998 A
5827506 McShane et al. Oct 1998 A
5833973 Dobkowski Nov 1998 A
5908707 Cabell Jun 1999 A
5977194 Mork Nov 1999 A
6033648 Candau Mar 2000 A
6060041 Candau et al. May 2000 A
6069169 Ptchelintsev et al. May 2000 A
6147131 Mork Nov 2000 A
6231837 Stroud et al. May 2001 B1
6303834 Mork Oct 2001 B1
6313181 Cohen Nov 2001 B1
6326033 Darmenton et al. Dec 2001 B1
6352701 Scholz et al. Mar 2002 B1
6383503 Bleckmann May 2002 B1
6399046 Schonrock et al. Jun 2002 B1
6423326 Shapiro Jul 2002 B1
6475500 Vatter Nov 2002 B2
6524598 Sunkel Feb 2003 B2
6548050 Bara Apr 2003 B1
6645474 Galdi et al. Nov 2003 B1
6685952 Ma et al. Feb 2004 B1
6696049 Vatter Feb 2004 B2
6699488 Deckner Mar 2004 B2
6747115 Sakuta Jun 2004 B2
6793929 Bleckmann Sep 2004 B2
7166276 Stephens et al. Jan 2007 B2
7175835 Simoulidis et al. Feb 2007 B1
7316808 Candau Jan 2008 B2
7416735 El-Nokaly et al. Aug 2008 B2
7462363 Braun Dec 2008 B2
7807188 Hoath et al. Oct 2010 B2
8241614 Carnali Aug 2012 B2
8299127 Anjing Oct 2012 B2
8398959 Yang et al. Mar 2013 B2
8425882 Lou et al. Apr 2013 B2
20020028184 Sunkel Mar 2002 A1
20020028223 Vatter et al. Mar 2002 A1
20020051755 Candau et al. May 2002 A1
20020106385 Vatter Aug 2002 A1
20020142018 Scholz et al. Oct 2002 A1
20030021815 Mondet Jan 2003 A9
20030044365 Candau Mar 2003 A1
20030049212 Robinson et al. Mar 2003 A1
20030082119 Golz-Berner et al. May 2003 A1
20030108498 Stephens et al. Jun 2003 A1
20030170193 Pate Sep 2003 A1
20030211061 Deckner Nov 2003 A1
20030211069 Deckner Nov 2003 A1
20030228339 El-Nokaly et al. Dec 2003 A1
20040014653 Smith Jan 2004 A1
20040047819 Hansenne et al. Mar 2004 A1
20040076597 Berens et al. Apr 2004 A1
20040086474 Rabe et al. May 2004 A1
20040091437 Fack et al. May 2004 A1
20040146472 Nakanishi Jul 2004 A1
20040185072 Hitzel et al. Sep 2004 A1
20040208903 Robinson et al. Oct 2004 A1
20040228821 Sunkel et al. Nov 2004 A1
20040235693 Wei Nov 2004 A1
20050002978 Crook et al. Jan 2005 A1
20050008600 Nakanishi Jan 2005 A1
20050089486 Spindler et al. Apr 2005 A1
20050118218 Cassin Jun 2005 A1
20050163812 Hoath et al. Jul 2005 A1
20050169856 Grollier Aug 2005 A1
20050175570 Inoue Aug 2005 A1
20050191326 Melker Sep 2005 A1
20050238595 Stella Oct 2005 A1
20060008426 Doring et al. Jan 2006 A1
20060013790 Shimizu Jan 2006 A1
20060078524 Midha Apr 2006 A1
20060078527 Midha et al. Apr 2006 A1
20060079417 Wagner et al. Apr 2006 A1
20060079422 Midha Apr 2006 A1
20060127344 Zofchak Jun 2006 A1
20060171909 Morrissey et al. Aug 2006 A1
20070009463 NiebaueR Jan 2007 A1
20070020217 Themens Jan 2007 A1
20070067924 Beck et al. Mar 2007 A1
20070173599 Liu Jul 2007 A1
20070231355 Quadir et al. Oct 2007 A1
20070292373 Russ et al. Dec 2007 A1
20080081057 Chevalier Apr 2008 A1
20080279793 Rudolph et al. Nov 2008 A1
20080279796 Handrosch et al. Nov 2008 A1
20080299058 Saito Dec 2008 A1
20080299156 Fares Dec 2008 A1
20080311058 Lou Dec 2008 A1
20080317693 Ricard Dec 2008 A1
20090035241 Cassin et al. Feb 2009 A1
20090041688 Dueva-Koganov et al. Feb 2009 A1
20090155321 Harichian et al. Jun 2009 A1
20090155322 Harichian et al. Jun 2009 A1
20090155373 Huang et al. Jun 2009 A1
20090178209 Koike et al. Jul 2009 A1
20090247445 Lou Oct 2009 A1
20090280147 Alberius et al. Nov 2009 A1
20100035783 Restrepo et al. Feb 2010 A1
20100209364 Abe et al. Aug 2010 A1
20100310483 Klug et al. Dec 2010 A1
20110150802 Bui et al. Jun 2011 A1
20110150805 Kergosien et al. Jun 2011 A1
20110150807 Bui et al. Jun 2011 A1
20110286942 Lou Nov 2011 A1
20110305649 Lou Dec 2011 A1
20110305651 Carnali Dec 2011 A1
20120039967 Lou et al. Feb 2012 A1
20120100083 Carnali Apr 2012 A1
20120141393 Yang Jun 2012 A1
20120189676 Susak et al. Jul 2012 A1
Foreign Referenced Citations (71)
Number Date Country
1816316 Aug 2006 CN
101068528 May 2011 CN
4122033 Jan 1993 DE
10049041 Apr 2002 DE
102004055541 May 2006 DE
102007013368 Sep 2008 DE
102008006857 Jan 2009 DE
1465530 Feb 1974 EP
0009404 Feb 1984 EP
0160430 Nov 1985 EP
0302147 Feb 1989 EP
0456545 Nov 1991 EP
0500446 Aug 1992 EP
810181 Dec 1997 EP
1210933 Jun 2002 EP
1352639 Oct 2003 EP
1481660 Dec 2004 EP
1581660 Dec 2004 EP
1600144 Nov 2005 EP
1741422 Jan 2007 EP
1849498 Oct 2007 EP
2087879 Aug 2009 EP
2380557 Oct 2011 EP
1864647 Nov 2011 EP
2651126 Mar 1991 FR
2894468 Dec 2005 FR
1465528 Feb 1977 GB
1465529 Feb 1977 GB
2139919 Nov 1984 GB
57091733 Jun 1982 JP
1281140 Nov 1989 JP
11158032 Jun 1999 JP
2004107249 Apr 2004 JP
2005314327 Nov 2005 JP
WO9217159 Oct 1992 WO
WO9403148 Feb 1994 WO
WO9415580 Jul 1994 WO
WO9421221 Sep 1994 WO
WO9526178 Oct 1995 WO
W09621721 Jul 1996 WO
9733560 Sep 1997 WO
WO 9733560 Sep 1997 WO
WO0100141 Jan 2001 WO
WO0107003 Feb 2001 WO
WO0128552 Apr 2001 WO
WO0189464 Nov 2001 WO
WO03022235 Mar 2003 WO
WO03075879 Sep 2003 WO
WO03080005 Oct 2003 WO
WO03086339 Oct 2003 WO
WO2004105721 Dec 2004 WO
WO2005004833 Jan 2005 WO
WO2005016302 Feb 2005 WO
WO2005025505 Mar 2005 WO
WO2006018149 Feb 2006 WO
WO2006102289 Sep 2006 WO
WO2007064687 Jun 2007 WO
WO 2008013757 Jan 2008 WO
WO2008013757 Jan 2008 WO
WO2008018046 Feb 2008 WO
WO2008155228 Dec 2008 WO
WO2009014061 Jan 2009 WO
WO2009053287 Apr 2009 WO
WO2009074513 Jun 2009 WO
WO2009083545 Jul 2009 WO
WO2009121787 Oct 2009 WO
WO2010009989 Jan 2010 WO
WO2010045163 Apr 2010 WO
WO2011075871 Jun 2011 WO
WO2011090821 Jul 2011 WO
WO2011157640 Dec 2011 WO
Non-Patent Literature Citations (10)
Entry
GB Search Report on Application No. GB1116661.8 dated Jan. 16, 2012.
Co-pending Application: Applicant: Carnali; U.S. Appl. No. 12/627,566, filed Nov. 30, 2009.
Co-pending Application: Applicant: Lou et al., U.S. Appl. No. 12/855,348, filed Aug. 21, 2010.
Co-pending Application: Applicant: Lou; U.S. Appl. No. 12/784,046, filed May 20, 2010.
Wikipedia, “Microemulsion”—Retrieved online Feb. 7, 2014—4 pages.
Carbopol® Aqua SF-1 Polymer, Lubrizol Technical Data Sheet, Feb. 7, 2013, pp. 1-9.
Shin-Etsu-Silicone for Personal Care, Shin-Etsu Chemical Co., Ltd., 2004, 1-6.
Dussaud, Liquid Transport in the Networked Microchannels of the Skin Surface, Langmuir, May 30, 2003, 7341-7345, 19, American Chemical Society, US.
LotionCrafter, Cyclomethicone and Essential Oils, Cyclomethicone and Essential 011s, 1-3, US.
Shin Etsu, Silicone Products for Personal Care-Shin-Etsu Unique Materials, ShinEtsu Silicone, 2007, 1-20.
Related Publications (1)
Number Date Country
20120100083 A1 Apr 2012 US